Silexion Therapeutics Corp (SLXN) Form S-1/A — Aug 10, 2026
Silexion Therapeutics filed an S-1/A for a best-efforts offering of up to 2,673,796 ordinary shares, each paired with an ordinary warrant, at an assumed $1.87 per share (the August 7, 2026 close), with H.C. Wainwright as exclusive placement agent and no minimum offering amount. At maximum size the deal would raise roughly $5.0 million gross ($4.3 million estimated net) but nearly triple shares outstanding from 1,349,019 to 4,022,815, about 198% dilution. A stated purpose is restoring compliance with Nasdaq's $2.5 million minimum shareholders' equity requirement, which the company is currently below during a mandatory Nasdaq panel monitoring period through September 23, 2026.
Key figures
- Cash Position
- 2400000
- Gross Proceeds
- approximately $5.0 million (2,673,796 shares x $1.87 assumed price)
- Offering Price
- 1.87
- Shares Offered
- 2673796
- Shares Outstanding
- 1,349,019 prior to offering; 4,022,815 after (assuming no pre-funded warrants or warrant exercises)
- Atm Capacity
- $13,170,000 ATM Agreement with H.C. Wainwright dated September 26, 2025
- Net Loss FY2025
- $11.9 million
- Reverse Splits
- ["1-for-9 (November 2024)","1-for-15 (July 2025)","1-for-10 (May 2026)"]
- Net Loss Q1 2026
- $2.7 million (vs $1.7 million Q1 2025)
- Dilution Percent
- ~198% increase in shares outstanding
- Warrant Coverage
- 1 ordinary warrant per share or pre-funded warrant; 5-year term; exercise price TBD
- Accumulated Deficit
- $57.9 million as of March 31, 2026
- Placement Agent Fees
- 7.0% cash fee plus 1.0% management fee of gross proceeds
- Nasdaq Equity Minimum
- $2.5 million minimum shareholders' equity requirement; company currently below it
- Estimated Net Proceeds
- approximately $4.3 million
- Offer Termination Date
- September 10, 2026
- Pre Funded Warrant Price
- $1.8699 with $0.0001 exercise price
- Placement Agent Warrants
- 187165
- Sponsor Note Outstanding
- $956,463 remaining under A&R Sponsor Promissory Note as of August 6, 2026
- May2026 Warrant Inducement Proceeds
- approximately $1.0 million gross
Price after filing
Close on the filing date to close N calendar days later (from $1.50). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.